Treatment of Tics in People with Tourette Syndrome and Chronic Tic Disorders
Neurol 92:896-906, Pringsheim, T.,et al, 2019
Pharmacotherapy for Diabetic Peripheral Neuropathy Pain and Quality of Life
Neurol 88:1958-1967, Waldfogel, J.M.,et al, 2017
Migraine
NEJM 377:553-561, Charles, A., 2017
Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache
Neurol 86:1818-1826, Simpson, D.M.,et al, 2016
Cerebral Palsy
Lancet 383:1240-1248, Colver, A.,et al, 2014
The Management of Spasticity in Adults
BMJ 349:g4737, Nair, K.P.S. & Marsden, J., 2014
OnabotulinumtoxinA Improves Quality of Life in Patients with Neurogenic Detrusor Overactivity
Neurol 81:841-848, Chancellor, M.B.,et al, 2013
Long-Term Improvement of Musicians Dystonia after Stereotactic Ventro-Oral Thalamotomy
Ann Neurol 74:648-654,627, Horisawa, S.,et al, 2013
OnabotulinumtoxinA Improves Quality of Life and Reduces Impact of Chronic Migraine
Neurol 77:1465-1472, Lipton, R.B.,et al, 2011
Practice Parameter: Pharmacologic Treatment of Spasticity in Children and Adolescents with Cerebral Palsy (an Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Neurol 74:336-343, Delgado,M.R.,et al, 2010
Tourettes Syndrome
NEJM 363:2332-2338, Kurlan,R., 2010
Botulinum toxin injections in the treatment of musician's dystonia
Neurol 64:341-343, Schuele, S., et al, 2005
Musician's dystonia
Neurol 64:186-187, Pullman, S.L. & Hristova, A.H., 2005
Long-Term Effect of Botulinum Toxin in Impairment and Functional Health in Cervical Dystonia
Neurol 50:1461-1463, Brans,J.W.M.,et al, 1998
Long Term Results of Botulinum Toxin Type A (Dysport) in the Treatment of Hemifacial Spasm:A Report of 175 Cases
JNNP 64:751-757, Jitpimolmard,S.,et al, 1998
Long-Term Botulinum Toxin Treatment of Focal Hand Dystonia
Neurol 44:70-76, Karp,B.I.,et al, 1994
Training Guidelines for the Use of Botulinum Toxin for the Treatment of Neurologic Disorders
Therap & Tech Assess Subcommit AAN, Neurol 44:2401-240394., , 1994
Clinical Correlates of Response to Botulinum Toxin Injections
Arch Neurol 48:1253-1256, Jankovic,J.&Schwartz,K.S., 1991
Infant Botulism:A Review of 12 Years'Experience at the Children; s Hosp of Phila
Pediatrics 87:159-165, Schreiner,M.S.,et al, 1991
Clinicopathologic Conference, Infant Botulism, Case 3-2024
NEJM 390:358-366, Case 3-2024, 2024
Trial of Botulinum Toxin for Isolated or Essential Head Tremor
NEJM 389:1753-1765, Marques,A.,et al, 2023
Disabling Jaw Clonus in a Patient with Bulbar-Onset Amyotrophic Lateral Sclerosis Successfully Treated with Botulinum Toxin
Neurol 99:671, Santos, M.O.,et al, 2022
Placebo-Controlled, Randomized, Double-Blind Study of IncobotulinumtoxinA for Sialorrhea
Neurol 92:e1982-e1991, Jost, W.H.,et al, 2019
Toxidrome Recognition in Chemical - Weapons Attacks
NEJM 378:1611-1620, Ciottone, G.R., 2018
Efficacy of Botulinum Toxin A for Treating Cramps in Diabetic Neuropathy
Ann Neurol 84:682-690, Restivo, D.A.,et al, 2018
Botulinum Toxin Type A for Neuropathic Pain in Patients with Spinal Cord Injury
Ann Neurol 79:569-578, Han, Z.A.,et al, 2016
Bilateral Hypertrophy of Masseteric and Temporalis Muscles, our Fifteen Patients and Review of Literature
Eur Rev Med Pharmacol Sci 20:7-11, Graziano, P.,et al, 2016
Evidence-Based Treatments for Adults with Migraine
Pain Reser Treat 2015:DOI:10.1155/2015/629382, Gooriah, R.,et al, 2015
Chronic Migraine
BMJ 348:g141b, Schwedt, T.J., 2014
The Treatment of Dystonic Tremor: A Systematic Review
JNNP 85:759-769, Fasano, A.,et al, 2014
Diagnosis and Management of Hyperhidrosis
BMJ 347:f6800, Benson, R.A.,et al, 2013
Botulinum Toxin A for Prophylactic Treatment of Migraine and Tension Headaches in Adults
JAMA 307:1736-1745, Jackson,J.L.,et al, 2012
A Musicians Dystonia
Lancet 379:2116, Vecchio, M.,et al, 2012
Essential Palatal Myoclonus
NEJM 362:e64, Scozzafava,J. &Yager,J., 2010
Botulinum Toxin for Diabetic Neuropathic Pain: A Randomized Double-Blind Crossover Trial
Neurol 72:1473-1478,1456, Yuan,R.-Y.,et al, 2009
Botulinum Toxin Type A for the Treatment of Headache: Why We Say Yes
Arch Neurol 65:146-149,151, Ashkenazi,A. &Silberstein,S., 2008
Headache Therapy With Botulinum Toxin: Form Over Substance
Arch Neurol 65:149-151,151, Pakalnis,A. &Couch,J., 2008
Update on Blepharospasm: Report from the BEBRF International Workshop
Neurol 71:1275-1282, Hallett,M.,et al, 2008
Primary Craniocervical Dystonia Presenting as a Respiratory Emergency
Neurol 68:388-389, Papapetropoulos,S.,et al, 2007
Clinical Update:Diagnosis and Treatment of Essential Tremor
Lancet 369:1152-1154, Benito-Leon,J&Louis,E.D., 2007
A Double-Blind, Controlled Study of Botulinum Toxin A in Chronic Myofascial Pain
Neurol 67:241-245, Qerama,E.,et al, 2006
Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006
Severe Tongue Protrusion Dystonia, Clinical Syndromes and Possible Treatment
Neurol 67:940-943, Schneider,S.A.,et al, 2006
A Double-blind Placebo-controlled Trial of Botulinum Toxin B for Sialorrhea in Parkinson's Disease
Neurol 62:37-40, Ondo,W.G.,et al, 2004
Botulinum Toxin Type A for Treating Voice Tremor
Arch Neurol 61:1416-1420, Adler,C.H.,et al, 2004
Neurological Aspects of Biological and Chemical Terrorism
Arch Neurol 60:21-25, Martin,C.O., &Adams,H.P., 2003
A Randomized Trial of Botulinum Toxin A for Treatment of Drooling
Neurol 61:1279-1281, Lipp,A.,et al, 2003
Botulinum Toxin A Treatment for Primary Hemifacial Spasm
Arch Neurol 59:418-420, Defazio,G.,et al, 2002
Botulinum Toxin for Cricopharyngeal Dysfunction in Parkinson's Disease
NEJM 346:1174-1175, Restivo,D.A.,et al, 2002